Literature DB >> 2027756

The reaction of platinum(II) complexes with DNA. Kinetics of intrastrand crosslink formation in vitro.

F Bernges1, E Holler.   

Abstract

The kinetics of the formation of bifunctional DNA platinum(II) adducts (DNA-crosslinks) have been investigated by endonuclease digestion and subsequent HPLC analysis of the soluble nucleotides and nucleotide platinum(II) adducts. The results indicate two waves of crosslinking [rate constants (0.2-0.3) min-1 and (0.015-0.025) min-1] that correlate with changes in ultra violet absorbance and ethidium bromide dependent fluorescence intensity, previously interpreted in terms of two consecutive, local conformational rearrangements of platinum-DNA (Schaller, W., Reisner, H., and Holler, E. (1987) Biochemistry 26, 943-950). The formation of crosslinks at sequences d(GpG) and d(GpNpG) follows identical kinetics. A minimal reaction mechanism is proposed for the binding of cis-diamminedichloroplatinum(II) to DNA under in vitro conditions. The approximately 3-fold higher rate for meso-[1,2-bis(2,6-dichloro-4- hydroxyphenyl)ethylenediamine]diaquaplatinum(II) in comparison to the rate for cis-diamminediaquaplatinum(II) indicates that crosslink formation is affected by the nature of the non-leaving platinum ligand(s).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027756      PMCID: PMC333905          DOI: 10.1093/nar/19.7.1483

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  The mechanism of action of antitumor platinum compounds.

Authors:  J J Roberts; A J Thomson
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1979

2.  Platinum compounds: a new class of potent antitumour agents.

Authors:  B Rosenberg; L VanCamp; J E Trosko; V H Mansour
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

3.  How does cisplatin alter DNA structure? A molecular mechanics study on double-stranded oligonucleotides.

Authors:  J Kozelka; J C Chottard
Journal:  Biophys Chem       Date:  1990-04       Impact factor: 2.352

4.  Interaction of aquated cis-[NH3)2Ptii]with nucleic acid constituents. 1. Ribonucleosides.

Authors:  W M Scovell; T O'Connor
Journal:  J Am Chem Soc       Date:  1977-01-05       Impact factor: 15.419

5.  Cis-diamminedichloroplatinum(II) modified DNA stimulates far greater levels of S1 nuclease sensitive regions than does the modification produced by the trans- isomer.

Authors:  W M Scovell; V J Capponi
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

6.  Synthesis and characterization of trans-[Pt(NH3)2Cl2] adducts of d(CCTCGAGTCTCC).d(GGAGACTCGAGG).

Authors:  C A Lepre; L Chassot; C E Costello; S J Lippard
Journal:  Biochemistry       Date:  1990-01-23       Impact factor: 3.162

7.  Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  A Schwartz; L Marrot; M Leng
Journal:  Biochemistry       Date:  1989-10-03       Impact factor: 3.162

8.  Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNA.

Authors:  N P Johnson; J D Hoeschele; R O Rahn
Journal:  Chem Biol Interact       Date:  1980-05       Impact factor: 5.192

9.  DNA supercoiling, shortening, and induction of single-strand regions by cis-diamminedichloroplatinum(II).

Authors:  S Mong; Y Daskal; A W Prestayko; S T Crooke
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

10.  Separation and characterization of products resulting from the reaction of cis-diamminedichloroplatinum (II) with deoxyribonucleosides.

Authors:  A Eastman
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

View more
  7 in total

1.  Monofunctional DNA-platinum(II) adducts block frequently DNA polymerases.

Authors:  E Holler; R Bauer; F Bernges
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.

Authors:  C Pérez; M Leng; J M Malinge
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

3.  [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer.

Authors:  T Spruss; S Schertl; M R Schneider; R Gust; K Bauer; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells.

Authors:  K A Grimaldi; S R McAdam; R L Souhami; J A Hartley
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

5.  Activation of the cisplatin and transplatin complexes in solution with constant pH and concentration of chloride anions; quantum chemical study.

Authors:  Tomáš Zimmermann; Jerzy Leszczynski; Jaroslav V Burda
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

6.  Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.

Authors:  D Payet; F Gaucheron; M Sip; M Leng
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

7.  Inhibition of cisplatin-mediated DNA damage in vitro by ribonucleotides.

Authors:  S Seki; A Hongo; B Zhang; K Akiyama; A H Sarker; T Kudo
Journal:  Jpn J Cancer Res       Date:  1993-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.